April 20, 2026 02:06 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pushback from smartphone makers: Centre drops Aadhaar app pre-install plan — report | Meta eyes first wave of layoffs on May 20: Report | TCS breaks silence on Nida Khan: ‘No HR role, no power’ in Nashik case | ‘Panic reaction’: Rahul Gandhi on women’s bill, says PM Modi ‘wants to send a message’ | Adani Group shares rise as Gautam Adani becomes Asia’s richest, overtakes Mukesh Ambani | TCS Nashik ‘conversion’ case accused seeks anticipatory bail citing pregnancy | IT raids TMC candidate Debasish Kumar’s premises ahead of Bengal polls | Bengal SIR: Supreme Court allows voters restored by tribunal till April 21 and 27 to vote | 'Women won't spare you': PM Modi warns Opposition over resistance to quota bill | Vijay booked in 3 cases over poll code violation ahead of Tamil Nadu polls
COVID19
Pixabay

US centers for disease control backs panel proposal for initial COVID-19 vaccine doses

| @indiablooms | Dec 04, 2020, at 02:59 pm

Washington/Sputnik: The US Centers for Disease Control and Prevention (CDC) adopted recommendations from an advisory panel that the first doses of a coronavirus vaccine be reserved for elderly care residents and health workers, according to a press release.

''[CDC Director Robert] Redfield supports their recommendations and has signed the memo and accepted these interim recommendations,'' the release said on Thursday.

On Tuesday, the CDC’s Advisory Committee on Immunization Practices recommended that initial vaccinations target 3 million residents in elderly care facilities and a portion of the nation’s 21 million healthcare workers.

Health workers such as nurses, whose jobs routinely place them within six feet of other people, would be first to receive the vaccine followed by workers able to follow CDC social distancing guidelines, the Advisory Committee said.

Vaccines made by Pfizer and Moderna have applied for emergency use authorization from the US Food and Drug Administration amid expectations of quick approval with first doses administered later this month. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.